Show
Sort by
-
Systematic safety follow-up in a cohort of 107 patients with spondylarthropathy treated with Infliximab: a new perspective of the role of host defence in the pathogenesis of the disease?
-
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
-
Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?